Cargando…
A multicenter study of genetic testing for Parkinson’s disease in the clinical setting
Parkinson’s disease (PD) guidelines lack clear criteria for genetic evaluation. We assessed the yield and rationale of genetic testing for PD in a routine clinical setting on a multicenter cohort of 149 early-onset and familial patients by exome sequencing and semi-quantitative multiplex ligation-de...
Autores principales: | Kovanda, Anja, Rački, Valentino, Bergant, Gaber, Georgiev, Dejan, Flisar, Dušan, Papić, Eliša, Brankovic, Marija, Jankovic, Milena, Svetel, Marina, Teran, Nataša, Maver, Aleš, Kostic, Vladimir S., Novakovic, Ivana, Pirtošek, Zvezdan, Rakuša, Martin, Vuletić, Vladimira, Peterlin, Borut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636217/ https://www.ncbi.nlm.nih.gov/pubmed/36333361 http://dx.doi.org/10.1038/s41531-022-00408-6 |
Ejemplares similares
-
A Systematic Review of Parkinson’s Disease Pharmacogenomics: Is There Time for Translation into the Clinics?
por: Vuletić, Vladimira, et al.
Publicado: (2021) -
Whole-Genome Sequencing in Diagnostics of Selected Slovenian Undiagnosed Patients with Rare Disorders
por: Bergant, Gaber, et al.
Publicado: (2021) -
The effects of microbiota abundance on symptom severity in Parkinson’s disease: A systematic review
por: Papić, Eliša, et al.
Publicado: (2022) -
Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective
por: Rački, Valentino, et al.
Publicado: (2023) -
Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)